Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportHematologic Malignancies

A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-cell Lymphoma

Russ Kuker, David Lehmkuhl, Deukwoo Kwon, Weizhao Zhao, Izidore Lossos, Craig Moskowitz, Juan Alderuccio and Fei Yang
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 3128;
Russ Kuker
1University of Miami Miller School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lehmkuhl
1University of Miami Miller School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deukwoo Kwon
1University of Miami Miller School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weizhao Zhao
1University of Miami Miller School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Izidore Lossos
2University of Miami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Moskowitz
1University of Miami Miller School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Alderuccio
3Sylvester Comprehensive Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Yang
2University of Miami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

3128

Introduction: Metabolic tumor volume (MTV) has been shown to be a strong independent prognostic factor in diffuse large B cell lymphoma (DLBCL). Calculating MTV can be tedious and time consuming using currently available semiautomatic software limiting its routine application in clinical practice. There can also be inherent variability to calculating MTV in that it requires manual input from the reader. Our goal was to develop a fully automated method for calculating MTV and to validate the algorithm by comparing the automated results with 2 experienced nuclear medicine (NM) readers.

Methods: The automated method designed for this study employed a deep convolutional neural network to segment normal physiologic structures from the CT scans which demonstrate intense avidity on FDG PET scans, including the brain, heart, kidneys, and bladder. The contours obtained for these structures were then automatically transferred and adapted to the PET scans according to their respective PET presentations. MTV was derived on the PET scans by thresholding with respect to 41% of the maximum SUV within the imaged body volume excluding the above-mentioned normal physiologic structures followed by filtering with a cutoff volume of 1 mL. The study cohort consisted of 50 patients with newly diagnosed DLBCL who were randomly selected from the Alliance/CALGB 50303 (NCT00118209) trial. De-identified imaging and clinical data were retrieved from The Cancer Imaging Archive (TCIA). MTV 41% and SUV of the lesion with the highest metabolic activity (SUV max) were analyzed for the included patients by 2 experienced NM physicians using the Hermes Affinity Viewer and compared to the fully automated results from the developed algorithm. For examining agreement, we estimated Pearson’s correlation coefficients and inter-class correlation coefficients (ICCs) along with corresponding 95% confidence intervals and p-values. For visualization, we displayed scatter plots and Bland-Altman plots between readers and the automated method. All tests were two-sided and statistical significance was considered when p<.05. Statistical software R was used for all statistical analyses.

Results: The mean MTV 41% calculated by reader 1 (R1) was 198.79 mL (standard deviation (SD) 283.26 and coefficient of variation (CV) 1.425), for reader 2 (R2) was 199.45 mL (SD 286.82 and CV 1.438) and for the automated method (AM) was 176.52 mL (SD 269.23 and CV 1.525). Comparing R1 to R2, the Pearson’s correlation coefficients and ICCs were 0.9996, p<.0001 and 1, p<.0001 (95%CI=1 to 1) for MTV 41% and 1, p<.0001 and 1, p<.0001 (95%CI=1 to 1) for SUV max, respectively. Comparing R1 to AM, the Pearson’s correlation coefficients and ICCs were 0.9768, p<.0001 and 0.97, p<.0001 (95%CI=0.94 to 0.98) for MTV 41% and 0.9968, p<.0001 and 1, p<.0001 (95%CI=0.99 to 1) for SUV max, respectively. Comparing R2 to AM, the Pearson’s correlation coefficients and ICCs were 0.9777, p<.0001 and 0.97, p<.0001 (95%CI=0.94 to 0.98) for MTV 41% and 0.9968, p<.0001 and 1, p<.0001 (95%CI=0.99 to 1) for SUV max, respectively (Figure). The Bland-Altman plots showed only relatively small systematic errors between the proposed method and the manual readings across the entire data range being examined for both MTV 41% and SUV max (Supplemental data). Limitations of the segmentation algorithm occur when tumor activity is located in close proximity to normal physiologic structures such as the bladder or kidneys or when normal anatomy has been distorted either due to the disease process or image artifacts such as misregistration or patient motion.

Conclusions: The proposed automated method for calculating MTV is robust demonstrating a high agreement with 2 experienced NM readers. In order to determine whether the observed variability is significant for the purpose of risk stratifying patients, further investigation is needed comparing our results with clinical outcome data which is currently ongoing.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-cell Lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-cell Lymphoma
Russ Kuker, David Lehmkuhl, Deukwoo Kwon, Weizhao Zhao, Izidore Lossos, Craig Moskowitz, Juan Alderuccio, Fei Yang
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3128;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-cell Lymphoma
Russ Kuker, David Lehmkuhl, Deukwoo Kwon, Weizhao Zhao, Izidore Lossos, Craig Moskowitz, Juan Alderuccio, Fei Yang
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3128;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Parameters on F-18 FDG PET/CT which predict treatment response and survival in paediatric and adolescent Hodgkin Lymphoma.
  • Inclusion of baseline FDG PET/CT and clinical data for an improved predictive risk model in non-Hodgkin lymphoma patients treated using CAR T-cell therapy
  • Testosterone replacement therapy (TRT) is associated with significant decline in testicular 18F-FDG activity in hypogonadal male patients with Erdheim Chester Disease (ECD).
Show more Hematologic Malignancies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire